<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
  "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         article-type="original-research-article">

  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JCARM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Contemporary Academic Research and Methodologies</journal-title>
        <abbrev-journal-title>JCARM</abbrev-journal-title>
      </journal-title-group>
            <issn pub-type="epub">3139-7247</issn>
            <publisher>
        <publisher-name>Ivory and Finch Publishers</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="doi">10.5281/zenodo.22807105</article-id>
      <article-id pub-id-type="publisher-id">JCARM_AUG_26_042</article-id>

      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research Article</subject>
        </subj-group>
      </article-categories>

      <title-group>
        <article-title>EVALUATION OF ANTIBACTERIAL ACTIVITY OF SENNA ALATA (L.ROXB.)  LEAVES AGAINST BACTERIA ASSOCIATED WITH HUMAN SKIN INFECTION</article-title>
      </title-group>

      <contrib-group>
        <contrib contrib-type="author">
          <name>
                        <surname>C.O</surname>
            <given-names>Aderotiba,</given-names>
          </name>
                    <aff>Department of Microbiology, Federal University of Technology, Akure, Ondo State, Nigeria</aff>
          <email>aderotibaolusola1@gmail.com</email>
        </contrib>
                                          <contrib contrib-type="author">
              <name>
                                <surname>A.K</surname>
                <given-names>Onifade,</given-names>
              </name>
                                          <aff>Department of Microbiology, Federal University of Technology Akure; Ondo State</aff>
                          </contrib>
                                    </contrib-group>

            <pub-date pub-type="epub">
        <day>17</day>
        <month>09</month>
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>7</issue>
      
      
            <self-uri xlink:href="https://doi.org/10.5281/zenodo.22807105"/>
      
      <abstract>
        <p>The increasing prevalence of antimicrobial resistance has reduced the effectiveness of conventional antibiotics, creating a need for continuous surveillance and the exploration of alternative therapeutic agents. This study aimed to determine the prevalence and characteristics of bacterial pathogens associated with skin infections, evaluate their antibiotic resistance patterns and assess the antibacterial potential of the plant extracts (Senna alata) as possible alternative treatments. A cross-sectional study was conducted involving forty (40) patients with clinically diagnosed skin infections. Demographic data were obtained, and swab samples were collected for bacteriological analysis. Isolates were identified using standard biochemical tests, hemolysis assays, antibiotic susceptibility testing, and multiple antibiotic resistance (MAR) index determination. Molecular confirmation was performed using 16S rRNA gene sequencing. Leaves of S. alata were extracted using aqueous, ethanol, and acetone solvents. Antibacterial activity was evaluated using agar diffusion, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) assays. Predominantly Gram-positive cocci, including Staphylococcus aureus (40.0%), Streptococcus pyogenes (36.66%), and Staphylococcus epidermidis (23.33%). Hemolysis testing showed 25.0% hemolytic strains. Antibiotic assay indicated complete sensitivity to rifampicin, ciprofloxacin, and levofloxacin, but high resistance to cefuroxime and ceftazidime. Multiple Antibiotic Resistance (MAR) indices ranged from 0.00 to 0.90, with most isolates exhibiting values ≥ 0.2, indicating exposure to high-risk antibiotic environments. Multidrug resistance was observed in 40.0% of the isolates, while several strains were extensively drug-resistant. These extracts demonstrated strong, concentration-dependent antibacterial activity, with inhibition zones up to 25 mm and MIC/MBC values ranging from 20–60 mg/mL, whereas aqueous extracts showed weaker effects. In conclusion, Gram-positive cocci, particularly S. aureus and S. pyogenes, are major etiological agents of skin infections. Organic solvent extracts of S. alata demonstrated promising antibacterial activity, suggesting their potential as alternative or adjunct therapeutic agents. Continuous antimicrobial surveillance and further pharmacological studies on plant-derived compounds are recommended to combat resistant skin pathogens.</p>
      </abstract>

            <kwd-group kwd-group-type="author-keywords">
                <kwd>Bacteriological Analysis</kwd>
                <kwd>Etiological Agents</kwd>
                <kwd>Pharmacological Studies</kwd>
                <kwd>Hemolysis Assays.</kwd>
              </kwd-group>
      
      <history>
        <date date-type="received">
          <day>15</day>
          <month>08</month>
          <year>2026</year>
        </date>
                <date date-type="accepted">
          <day>10</day>
          <month>09</month>
          <year>2026</year>
        </date>
              </history>

      <permissions>
        <copyright-statement>Copyright &copy; 2026 by the authors</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.</license-p>
        </license>
      </permissions>

    </article-meta>
  </front>

    <back>
    <ref-list>
      <title>References</title>
                      <ref id="ref-1">
          <mixed-citation>Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. and Supuran, C. T. (2021). Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery, 20 (3), 200–216.</mixed-citation>
        </ref>
                              <ref id="ref-2">
          <mixed-citation>Clinical and Laboratory Standards Institute (CLSI) (2016). Performance Standards for Antimicrobial Susceptibility Testing. 26th Edition, Wayne.</mixed-citation>
        </ref>
                              <ref id="ref-3">
          <mixed-citation>Flores-Mireles, A. L., Walker, J. N., Caparon, M., and Hultgren, S. J. (2015). Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology, 13(5): 269–284.</mixed-citation>
        </ref>
                              <ref id="ref-4">
          <mixed-citation>Grice, E. A., and Segre, J. A. (2011). The skin microbiome. Nature Reviews Microbiology,9(4), 244-253.</mixed-citation>
        </ref>
                              <ref id="ref-5">
          <mixed-citation>Kavanagh, K. T., Abusalem, S., and Calderon, L. E. (2018). The incidence of MRSA infections in the United States: Is a more comprehensive tracking system needed? Antimicrobial Resistance and Infection Control, 7(1), 34.</mixed-citation>
        </ref>
                              <ref id="ref-6">
          <mixed-citation>Laxminarayan, R., Van Boeckel, T., Frost, I., Kariuki, S. and Peacock, S. J. (2020). The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later. The Lancet Infectious Diseases, 20(4), e51-e60.</mixed-citation>
        </ref>
                              <ref id="ref-7">
          <mixed-citation>Miller, L. G., Eells, S. J., Taylor, A. R., et al. (2019). Staphylococcus aureus colonization among household contacts of patients with skin infections. Clinical Infectious Diseases, 69(6), 1018–1025.</mixed-citation>
        </ref>
                              <ref id="ref-8">
          <mixed-citation>Newman, D. J. and Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803.</mixed-citation>
        </ref>
                              <ref id="ref-9">
          <mixed-citation>O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. London: Wellcome Trust.</mixed-citation>
        </ref>
                              <ref id="ref-10">
          <mixed-citation>Osundiya O., Oladele R., and Oduyebo O. (2013) Multiple Antibiotic   Resistance (Mar)Indices  Of Pseudomonas And Klebsiella Species Isolates In Lagos University Teaching Hospital. Afr. J. Cln. Exper. Microbiol. 14(3): 164-168</mixed-citation>
        </ref>
                              <ref id="ref-11">
          <mixed-citation>Otto, M. (2018). Staphylococcal biofilms. Microbiology Spectrum, 6(4), 1–20.</mixed-citation>
        </ref>
                              <ref id="ref-12">
          <mixed-citation>Peacock, S. J., and Paterson, G. K. (2015). Mechanisms of methicillin resistance in Staphylococcus aureus. Annual Review of Biochemistry, 84, 577–601.</mixed-citation>
        </ref>
                              <ref id="ref-13">
          <mixed-citation>Sarker S.D., Latif Z., and Gray A.I. (2006). Natural product isolation (2nd ed., pp.27-46)</mixed-citation>
        </ref>
                              <ref id="ref-14">
          <mixed-citation>Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., et al. (2019). Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nature Reviews Microbiology, 17(4), 203–218.</mixed-citation>
        </ref>
                              <ref id="ref-15">
          <mixed-citation>World Health Organization (WHO). (2021). Antimicrobial resistance. Retrieved from [https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance] (https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</mixed-citation>
        </ref>
                              <ref id="ref-16">
          <mixed-citation>World Health Organization. (2023). Global antimicrobial resistance and use surveillance system (GLASS) report. Geneva:</mixed-citation>
        </ref>
                              <ref id="ref-17">
          <mixed-citation>Yusha,u M., Onuorah F. C., and Yau M.(2010). In vitro sensitivity pattern of some urinary tract isolates to Carica papaya extracts. Bayero journal of pure and Applied Sciences, 2(2), 75-78.</mixed-citation>
        </ref>
                  </ref-list>
  </back>
  
</article>
